anonymous
Guest
anonymous
Guest
SOLD,
We are looking to invest in a division that actually makes $
We are looking to invest in a division that actually makes $
We shall seeConjunctivitis drug will NEVER come to market. Trial enrollment too difficult. X sold to N. We all walk.
Care to share a range or number?Same here - - - DOABLE!!
xiidra does make money - however could be making a shit loads more if the launch was done rightSOLD,
We are looking to invest in a division that actually makes $
Dang!Hey JM in Chicago looks like all your reps are leaving you...dropping like flies. That must reflect well on you huh? Don't worry you'll be bought out by Novartis soon enough. Hope that severence is a big one. Karma is a bitch isn't it?
xiidra does make money - however could be making a shit loads more if the launch was done right
Another one bites the dust huh!?Hey JM in Chicago looks like all your reps are leaving you...dropping like flies. That must reflect well on you huh? Don't worry you'll be bought out by Novartis soon enough. Hope that severence is a big one. Karma is a bitch isn't it?
Same here - - - DOABLE!!
Seriously, either way you slice it there were like 10 people who actually grew last qtr so well see what pipe they are smoking when goals are 30% increase againDon’t you all love it when the same person makes three consecutive posts, trying to appear as three different people.
That entire team has turned over in the last 6 months, it's all new people.Another one bites the dust huh!?
WRONG!! ~70% of the OBU sales force grew Rxs last QTR!! Go away troll!Seriously, either way you slice it there were like 10 people who actually grew last qtr so well see what pipe they are smoking when goals are 30% increase again
WRONG!! ~70% of the OBU sales force grew Rxs last QTR!! Go away troll!
dare you to quote growth versus prior year...and versus the previous year also. Bottom line is it at least flat....
Don’t confuse scripts with revenue. Scripts are flat to decreasing (product NOT growing). Revenue is up BUT still not profitable. X is a dying brand!
Don’t confuse scripts with revenue. Scripts are flat to decreasing (product NOT growing). Revenue is up BUT still not profitable. X is a dying brand!
Net sales does not equal scripts you dumb ass! AND, nothing JS has told us has been truthful so why should we believe him now?